VIRNICH DANIEL (Chief Operating Officer) received a stock award from STARLING ONCOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/1/2026ACC: 0001079973-26-000439
Officer· Chief Operating Officer
Since Nov 2021
-769.14K
Net shares
Net seller
$302.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
769.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−670.61K
Price / share
—
Trade value
—
% of position
21.4%
3/27/2026
3.13M→2.46M
Common Stock
Direct
Shares
−98.53K
Price / share
$3.07
Trade value
$302.50K
% of position
4.0%
3/27/2026
2.46M→2.36M
Total
Net shares
−769.14K
Net value
-$302.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2026 | A · Award | −670.61K | — | — | 21.4% | 3.13M | 2.46M |
| Common Stock Direct | 3/27/2026 | J · J | −98.53K | $3.07 | $302.50K | 4.0% | 2.46M | 2.36M |
| Total | −769.14K | -$302.50K | ||||||
Derivative Transactions0
No derivative transactions reported